Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04257448
Title Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer (SEPION)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GWT-TUD GmbH
Indications

pancreatic ductal adenocarcinoma

Therapies

Gemcitabine + Nab-paclitaxel + Romidepsin

Azacitidine + Gemcitabine + Nab-paclitaxel

Azacitidine + Gemcitabine + Nab-paclitaxel + Romidepsin

Gemcitabine + Nab-paclitaxel

Durvalumab + Lenalidomide

Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.